1.22
price down icon5.43%   -0.07
after-market Handel nachbörslich: 1.23 0.01 +0.82%
loading

Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten

pulisher
Nov 17, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

ALX Oncology FY2024 EPS Forecast Raised by Cantor Fitzgerald - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Significant Decrease in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Brokers Set Expectations for ALX Oncology FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Former Mirati CMO Alan Sandler joins ALX Oncology - The Pharma Letter

Nov 14, 2024
pulisher
Nov 14, 2024

Data-Based Insights About XBP Europe Holdings Inc (XBP) - Stocks Register

Nov 14, 2024
pulisher
Nov 14, 2024

New Outlook On Celsius Holdings Inc - Stocks Register

Nov 14, 2024
pulisher
Nov 14, 2024

ALX Oncology Strengthens Leadership with Key Appointment - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

ALX Oncology Appoints Former Mirati & Genentech Exec as Chief Medical Officer | ALXO Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Cantor Fitzgerald Reiterates Overweight Rating for ALX Oncology (NASDAQ:ALXO) - Defense World

Nov 14, 2024
pulisher
Nov 13, 2024

ALXO stock touches 52-week low at $1.31 amid market challenges - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC's Strategic Reduction in ALX Oncology Holdings Inc Shares - GuruFocus.com

Nov 13, 2024
pulisher
Nov 11, 2024

Analysts Offer Predictions for ALX Oncology FY2028 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

ALX Oncology Highlights Promising Trial Results - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 07, 2024
pulisher
Nov 04, 2024

ALX Oncology Announces November Investor Conference Participation - GlobeNewswire

Nov 04, 2024
pulisher
Nov 03, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

ALXOALX Oncology Holdings Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024
pulisher
Nov 01, 2024

ALX Oncology Announces Results from Phase 1b/2 Trial of - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 - StockTitan

Nov 01, 2024
pulisher
Oct 30, 2024

ALXO stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia

Oct 30, 2024
pulisher
Oct 29, 2024

ALXO stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

SG Americas Securities LLC Has $50,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 29, 2024
pulisher
Oct 16, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Down 6.7% in September - MarketBeat

Oct 16, 2024
pulisher
Oct 14, 2024

Technical analysis of Alx Oncology Holdings Inc (ALXO) stock chart patterns - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

ALXO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle

Oct 11, 2024
pulisher
Oct 11, 2024

Closing Figures: Alx Oncology Holdings Inc (ALXO)’s Negative Finish at 1.44, Down -11.11 - The Dwinnex

Oct 11, 2024
pulisher
Oct 11, 2024

SVP, FINANCE AND CAO Pinto Shelly sale 564 shares of Alx Oncology Holdings Inc [ALXO] - Knox Daily

Oct 11, 2024
pulisher
Oct 10, 2024

Millennium Management LLC Reduces Stake in ALX Oncology Holdings Inc - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

ALXO stock touches 52-week low at $1.55 amid market challenges By Investing.com - Investing.com South Africa

Oct 10, 2024
pulisher
Oct 10, 2024

ALXO stock touches 52-week low at $1.55 amid market challenges - Investing.com

Oct 10, 2024
pulisher
Oct 09, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $12.20 Average PT from Brokerages - MarketBeat

Oct 09, 2024
pulisher
Oct 06, 2024

ALX Oncology Holdings Drops To US$1.68, Yet Insiders May Have Sold Too Early - Simply Wall St

Oct 06, 2024
pulisher
Oct 05, 2024

American Century Companies Inc. Cuts Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

A company insider recently sold 564 shares of Alx Oncology Holdings Inc [ALXO]. Should You Sale? - Knox Daily

Oct 04, 2024
pulisher
Oct 04, 2024

ALX Oncology Chief Medical Officer resigns, search for replacement begins - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

Point72 Asset Management L.P. Makes New $1.83 Million Investment in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

ALX Oncology CMO Sophia Randolph Announces Resignation - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

ALX Oncology Chief Medical Officer resigns, search for replacement begins By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

ALX Oncology Holdings Inc. Announces Resignation of Sophia Randolph as Chief Medical Officer, Effective October 11, 2024 - Marketscreener.com

Oct 04, 2024
pulisher
Oct 04, 2024

Point72 Asset Management L.P. Acquires New Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

ALXO stock touches 52-week low at $1.75 amid market challenges By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

ALXO stock touches 52-week low at $1.75 amid market challenges - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Marshall Wace LLP Has $3.83 Million Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 03, 2024
pulisher
Oct 02, 2024

You might want to take a look at Alx Oncology Holdings Inc (ALXO) now - SETE News

Oct 02, 2024
pulisher
Oct 02, 2024

Renaissance Technologies LLC Increases Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Oct 01, 2024
pulisher
Oct 01, 2024

ALXO’s 2023 Market Dance: Down -87.78% – Time to Invest? - The InvestChronicle

Oct 01, 2024
pulisher
Oct 01, 2024

Alx Oncology Holdings Inc (ALXO)’s results reveal risk - US Post News

Oct 01, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):